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Introduction 
 
In 1984, the first liver transplant in Catalonia and Spain was performed in Bellvitge 
University hospital, in 1985, Vall d’Hebron Children’s Hospital began work in this field 
and Vall d’Hebron General Hospital and Hospital Clínic were authorized in 1988. 
 
The Catalan Liver Transplant Registry (RTHC) began operation in 1994 and contains 
data on the transplants carried out in Catalonia since 1984, the data on transplants 
performed between 1984 and 1993 were collected retrospectively. The registry has 
collected data periodically and systematically since 1994. 
 
In accordance with its objectives, the registry responds to the information 
requirements of the Catalan Health Service (Servei Català de la Salut) and of the 
Catalan Department of Health for planning and managing resources and purchasing 
services, the registry is also a source of information that can be accessed by 
professionals working in the field of health care and also serves demand from other 
areas, in all cases, release of data from RTHC is subject to the current legislation on 
the treatment and use of personal data. 
 
Obtaining this body of information is proof of the results that can be achieved from 
collaboration between health care professionals and the authorities in order to 
develop and consolidate instruments that allow health care and service policies to be 
made effective. 
 
The main objective of this document is to publicise the activity, characteristics and 
results of the liver transplants carried out in Catalonia between 1984 and 2017, both 
for the professionals directly involved in this treatment and for the health care 
authorities. 
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Methodological Aspects and Definitions 
 
The report is divided into three sections: the first section provides a brief descriptive 
analysis of the evolution of liver transplants in Catalonia using global data from the 
registry; the second and third sections provide specific data for adults and children.  
 
The last two sections analyse the characteristics of the recipients, donors, 
transplants and results obtained, recipient characteristics include patient data at the 
time of the first transplant, thereby excluding patients who received their first 
transplant outside Catalonia (also excluded are adults who received their first 
transplant as children) and who received a retransplant in Catalonia.   
 
The same classification of indication and causes of failure and death have been used 
as in previous reports, the 2002-2003 report, available from the OCATT website, 
describes in detail the codes for disease and failure included in each of the 
categories.  
 
Patient survival (time until death) and graft survival (time until graft failure or patient 
death), were calculated using the Kaplan- Meier method and the level of statistical 
significance between the different curves was determined using the Log-rank test, 
survival curves were interrupted when the number of cases was below 10 and 
patients who, previously or subsequently, underwent a transplant in another hospital 
were excluded. 
 
The probability of receiving a transplant was calculated taking into account a model 
of competitive risks with three events of interest: transplant, death and removal from 
the waiting list.  
 
 
Description of indicators:  
 
Annual rate of liver transplants in Catalonia 
Total number of transplants performed in a year in authorized hospitals, 
independently of place of residence of recipient and origin of donor with respect to 
the population of Catalonia (population census of 1991 and 1996, and annual census 
updates from 1997 onward Instituto Nacional de Estadística), figures per million 
population (pmp).  
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Evolution of Liver Transplants 
 
In Catalonia, a total of 5215 liver transplants were carried out on 4785 patients (435 
were retransplants) between 1984 and 2017. Whereas in 2017, a total of 160 
transplants were carried out (14 retransplants). 
 
The annual evolution of the number of liver transplants has shown a growing trend 
(Figure 1), to stabilize at 200 annual transplants, but a decreasing tendency in recent 
years. During the last year seven less transplants has been performed than previous 
year.  
 
Figure 1.Annual Evolution of Number of Transplants and Rate of Liver Transplants, 1984-
2017 
 
 
 
The same trend can be seen in the annual rate of liver transplant (Figure 1), which 
reached 21.2 transplants per million population (pmp) in 2017, the rate vary 
considerably among countries (Figure 2).  
 
These data should be interpreted taking into account the different factors that affect 
the transplant workload in each country, such as the health care system, indication 
criteria, population structure and cultural aspects. 
 
A total of 86.0% (4117) of patients who underwent transplant were residents in 
Catalonia, 13.0% (621) were resident in the rest of Spain and 0.8% (37) were from 
abroad. This information was not available for 10 patients.  
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Figure 2. Liver Transplant Rates in Different Countries, 2017 
 
 
 
Of the 5215 transplants carried out in Catalonia throughout the entire period, 4888 
were performed in adult patients (4499) and 327 were performed in paediatric 
patients (287). In 2017, 150 transplants were carried out on adults and 10 on 
children.  
 
Figure 3.Number of Patients who Received Liver Transplants by Age Group and Sex. 1984-
2017 
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The mean age of patients who received a first liver transplant was 50 years and the 
median was 54 years (SD, 15.6 y; range, 0-73 y). The age group with the highest 
number of cases was the 55-59 years group (Figure 3), which represents 19,4% of all 
patients. In 2017, patients over the age of 60 years represented 30.8% of patients; 
this figure was 11.6% in 1992. Overall, this group represents 26.7% of patients who 
received a first transplant.  
 
Differences can be seen in the distribution of the indications in different areas in our 
region, which may be due to different inclusion criteria for patients on the waiting list 
and to differences in the way the data is processed (Figure 4). For example, in the 
case of the European registry (ELTR), the category of tumours includes 
hepatocellular carcinomas and other liver cancers, whereas the Spanish liver 
transplant registry (RETH) and the Catalan registry (RTHC) only includes 
hepatocellular carcinomas, with or without cirrhosis, in this category.  
 
Figure 4. Indications of the First Liver Transplant in Patients of All Ages. Comparative Data 
From the European Registries (ELTR)
1
, Spanish Registry (RETH)
2
 and Catalan Registry 
(RTHC). 1984-2017 
 
 
 
The most frequent indication in Catalonia is cirrhosis (47.0%), followed by 
hepatocellular carcinoma (31.7%), although there are differences according to 
recipient age (Figure 5). In paediatric patients, the most frequent indications are 
congenital biliary diseases, grouped in the “others” category.   
 
Given the differences between the characteristics of the transplants performed in 
adult patients and in children, both in terms of indications and of the transplant itself 
and its course, the results obtained in each of these populations are analyzed 
separately. 
 
                                               
1
 European Liver Transplant Registry 1988-2015 (available at: http://www.eltr.org) 
2
 Spanish Liver Transplant Registry, annual Report of Results, 1984-2016 (available at: 
http://www.sethepatico.org).  
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Figure 5.Percentage of Patients who Received Liver Transplants by Principal Diagnosis and 
Age Group. 1984-2017 
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Liver Transplants in Adults 
 
Of the 5215 transplants carried out in Catalonia throughout the 1984-2017 period, 
4888 were performed in adult patients: 4493 first transplants and 395 retransplants. 
These transplants were carried out on 4499 patients; five patients received the first 
transplant outside Catalonia and one was not an adult when the first transplant was 
received (Figure 6).  
 
In 2017, a total of 150 were performed in adult patients: 136 first transplants and 14 
retransplants.  
 
Figure 6. Evolution of Number of Liver Transplants: Adult Patients. 1984-2017 
 
 
 
Recipient Characteristics 
 
 Sex and age  
 
Of the 4493 patients who received a first transplant in Catalonia during the 1984-
2017 period, 3060 (68.1%) were men and 1433 (31.9%) were women. The proportion 
of women has decreased over the years and has gone from 44.0% in the 1984-1991 
period to 25.8% in the 2012-2017 period. Specifically, in 2017, the proportion of 
women was 26.5%.  
 
The mean age of patients who received a first liver transplant in the 1984-2017 
period was 53 years, the median was 55 years and the maximum was 73 years.   
The mean age has gone from 49.4 years in 1992 (range, 17-65 y; 95% CI, 47.3-
51.5y) to 56.0 years in 2017 (range, 20-70 y; 95% CI, 54.5-57.6 y) (Figure 7), the 
early years show a progressive increase in the mean age, which stops in 1999, to 
stabilize at between 53 and 54 years.  
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With regard to distribution by age groups, the percentage of patients over 60 years of 
age has increased from 12.2% in 1992 to 33.1% in 2017.  
 
Figure 7. Evolution of the Age of Patients who Received a First Liver Transplant: Adult 
Patients. 1992-2017 
 
 
 
 Indications 
 
The indications are grouped into six categories: acute liver failure (ALF), cholestatic 
liver disease, cirrhosis (without hepatocellular carcinoma), hepatocellular carcinoma, 
metabolic disease and others, in accordance with the code recorded in the principal 
diagnosis. With the exception of patients with hepatocellular carcinoma, who were 
grouped in a separate category, the principal and secondary diagnoses were taken 
into account, although some cases may involve incidental tumours.  
 
In the 1984-2017 period, almost three-quarters of transplanted patients (with a first 
transplant) belong to only two of these six groups: 49.7% presented cirrhosis (without 
hepatocellular carcinoma) and 33.6% presented hepatocellular carcinoma (Figure 8). 
These percentages are 42.6% and 42.6%, respectively, in the first transplants carried 
out in 2017.  
 
Hepatocellular carcinomas are the indications that have most increased over the 
years and currently represent three times the percentage observed in 1992, although 
the trend has not grown throughout all of these years (Figure 9).  
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Figure 8. Principal Diagnosis of First Liver Transplant: Adult Patients. 1984-2017 
 
 
 
Figure 9. Evolution of Principal Diagnosis of First Liver Transplant: Adult Patients. 1992-2017 
 
 
 
Cirrhosis is the most frequent group of indications in patients over 30 years of age, 
but as age increases, the proportion of transplants in which the indication is 
hepatocellular carcinoma, which represents 50.4% of all diagnoses in patients over 
60 years of age (Figure 10). 
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Figure 10. Principal Diagnosis of First Liver Transplant by Age Group: Adult Patients. 1984-
2017 
 
 
 
Patients with acute liver failure are the youngest, in contrast to patients with 
hepatocellular carcinoma, who are the oldest (p<0.001) (Table 1). 
 
Table 1. Mean and Confidence Interval of Age for Principal Diagnosis: Adult Patients. 1984-
2017 
 
 
 
The diagnoses of cholestatic liver disease and acute liver failure are more frequent in 
women than in men, in contrast, hepatocellular carcinoma occurs more frequently in 
men than in women (Figure 11). 
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Figure 11. Principal Diagnosis of First Liver Transplant by Period and Recipient Sex: Adult 
Patients. 1984-2017 
 
 
 
Acute liver failure 
This indication represents 5.0% (226) of transplanted patients in the 1984-2017 
period. In most cases (80.1%, 181 patients), it is fulminant or subfulminant hepatitis - 
either viral or due to unknown causes.   
In 2017, 5.1% (7) of transplanted patients presented acute liver failure; due to 
fulminant or subfulminant hepatitis. 
 
 
Cholestatic liver disease  
Cholestatic liver disease is one of the less frequent diagnosis groups, with 235 
(5.2%) cases for the same period. Primary biliary cirrhosis represents 65.5% (154) of 
all cases and sclerosing cholangitis represents 28.1% (66).   
Some 2.9% (4) of patients who received a transplant in 2017 presented a cholestatic 
disease, two had a sclerosing cholangitis, one a primary biliary cirrhosis and one a 
secondary biliary cirrhosis. 
 
 
Cirrhosis (without hepatocellular carcinoma) 
This is the most frequent indication, with 2232 patients - 49.7% of the total. Alcoholic 
cirrhosis and cirrhosis due to the hepatitis C virus are the most frequent (Figure 12).  
Cirrhosis (without hepatocellular carcinoma) represents 42.6% (58) of patients who 
received a first liver transplant in 2017; 44.8% (26) of whom had alcoholic cirrhosis, 
12,1% (7) had cirrhosis due to hepatitis C virus and 13.8% (8) had both alcoholic 
cirrhosis and cirrhosis due to hepatitis C virus (Figure 13). In the last year we 
observe an increase in the number of transplanted patients with NASH cirrhosis 
included in the “Others and related” category, and a decrease in the number of 
transplanted patients with cirrhosis due to hepatitis C virus. 
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Figure 12. Principal Diagnosis of Cirrhosis in the First Transplant: Adult Patients. 1984-2017 
 
 
 
Figure 13. Evolution of Principal Diagnosis of Cirrhosis in the First Liver Transplant: Adult 
Patients. 1992-2017 
 
 
 
Hepatocellular carcinoma  
This type of carcinoma represents 33.6% (1509) of patients who received transplants 
in the 1984-2017 period and is the second most frequent indication. Of these cases, 
98.0% are accompanied by cirrhosis - in most cases, cirrhosis due to the hepatitis C 
virus (Figures 14 and 15). Of the patients who received a transplant in 2017, 42.6% 
(58) had a hepatocellular carcinoma.   
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Figure 14. Principal Diagnosis of Hepatocellular Carcinoma in the First Liver Transplant: 
Adult Patients. 1984-2017 
 
 
 
Figure 15. Evolution of Principal Diagnosis of Hepatocellular Carcinoma in the First Liver 
Transplant: Adult Patients. 1992-2017 
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Metabolic disease  
Of patients who received a transplant in this period, 150 cases (3.3%) had a 
metabolic disease, in most cases (75.3%, 113 patients), the disease was a familial 
amyloidotic polyneuropathy.   
Of the 136 patients who received a transplant in 2017, 3 (2.2%) had a metabolic 
disease as the principal diagnosis; specifically a familial amyloidotic polyneuropathy. 
 
Others 
This is the least frequent group of indications, with 141 patients (3.1%), in the 1984-
2017 period. 
Of the other indications for transplant, 47 presented some type of malignant tumour, 
36 a benign tumour or polycystic disease, 24 presenting a congenital liver disease, 
18 Budd-Chiari disease, and 16 more presented another type of liver disease.  
Six patients (4.4%) who received transplants in 2017 had an indication belonging to 
this group; two with polycystic disease, two with malignant tumour, one with Caroli 
disease and one with Budd-Chiari.  
 
 
 Infection by hepatitis B and C viruses  
 
The proportion of HBSAg-positive adult patients in the 1984-2017 period was 7.6%; 
this number has remained relatively stable in recent years (Figure 16). 
 
A total of 46.8% of patients who received a transplant in the 1984-2017 period were 
HCV-positive. A decrease in the percentage of patients with HCV-positive has been 
observed recently due to the appearance of the direct-acting antivirals. 
 
Figure 16. Annual Evolution of Percentage of Adult Patients who Tested Positive for HVB and 
HCV. 1992-2017 
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 HIV infection  
 
The first four liver transplants in patients infected with HIV were performed in 2002, 
since then, 98 transplants (92 patients) have been performed - 3 of them in 2017.  
 
Of these patients, 56.5% (52) had cirrhosis as an indication, principally due to HCV, 
and 38.0% (35) had a hepatocellular carcinoma.  
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Donor Characteristics 
 
 Type 
 
94.2% of all transplants in 1984-2017 period were performed using organs from 
brain-death cadaveric donors (taken into account the 1992-2017 period was 93.7%). 
 
Since 1998 other types of donors have been used; non-heart-beating donors, domino 
and living (Figure 17). Together, non-heart-beating, domino and living donors 
represent 11.3% of all donors in 2017 (Table 2).  
 
Figure 17. Evolution of Number of Living, Domino and Non-heart-beating Donor Transplants 
in Adult Patients. 1998-2017 
 
 
 
 Age and sex  
 
The mean age of liver donors was 49 years in the 1992-2017 period; this figure has 
increased gradually over the years and has gone from 33 years (95% CI, 29.9-35.3 y; 
maximum age, 65 y) in 1992 to 56 years (95% CI, 52.9-58.2 y; maximum age, 84 y) 
in 2017 (Figure 18).  
This increase has occurred in the oldest donors, given that, in 2017, 21.3% (32) were 
70 years old or more, whereas this age group did not exist in 1992. In contrast, 
donors under the age of 40 years, who represented 65.9% (83) of all cases in 1992, 
had fallen to 15.3% (23) by 2017.  
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Table 2.Evolution of Donor Type: Transplants in Adult Patients. 1998-2017 
 
 
Figure 18. Evolution of Donor Age in Transplants in Adult Patients. 1992-2017 
 
n % n % n % n %
1998 184 (99,5%) 1 (0,5%) 185
1999 182 (98,4%) 3 (1,6%) 185
2000 164 (93,2%) 5 (2,8%) 7 (4,0%) 176
2001 176 (90,3%) 9 (4,6%) 10 (5,1%) 195
2002 166 (87,4%) 1 (0,5%) 10 (5,3%) 13 (6,8%) 190
2003 200 (90,9%) 2 (0,9%) 9 (4,1%) 9 (4,1%) 220
2004 184 (94,4%) 3 (1,5%) 4 (2,1%) 4 (2,1%) 195
2005 200 (92,2%) 4 (1,8%) 6 (2,8%) 7 (3,2%) 217
2006 182 (94,3%) 2 (1,0%) 3 (1,6%) 6 (3,1%) 193
2007 183 (89,7%) 7 (3,4%) 9 (4,4%) 5 (2,5%) 204
2008 186 (90,7%) 4 (2,0%) 9 (4,4%) 6 (2,9%) 205
2009 179 (94,2%) 4 (2,1%) 5 (2,6%) 2 (1,1%) 190
2010 132 (87,4%) 8 (5,3%) 3 (2,0%) 8 (5,3%) 151
2011 169 (94,9%) 1 (0,6%) 5 (2,8%) 3 (1,7%) 178
2012 160 (93,6%) 2 (1,2%) 5 (2,9%) 4 (2,3%) 171
2013 141 (89,2%) 6 (3,8%) 4 (2,5%) 7 (4,4%) 158
2014 136 (91,9%) 5 (3,4%) 2 (1,4%) 5 (3,4%) 148
2015 137 (92,6%) 7 (4,7%) 4 (2,7%) 148
2016 131 (86,8%) 16 (10,6%) 1 (0,7%) 3 (2,0%) 151
2017 133 (88,7%) 14 (9,3%) 2 (1,3%) 1 (0,7%) 150
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Taking into account the type of donor, the living donors are the youngest (Table 3).  
 
Table 3. Donor Characteristics: Transplants in Adult Patients. 1998-2017 
 
 
 
In the 1992-2017 period, 60.9% (2756) of donors were men and 39.1% (1771) were 
women, in 2017, 57.3% (86) were men and 42.7% (64) were women.  
 
The mean age of male donors in the 1992-2017 period was 47 years (SD, ±18.4 y; 
95% CI, 46.4-47.8 y; maximum age, 87 y) and that of women was 52 years (SD, 
±17.4 y; 95% CI, 51.3-52.9 y; maximum age, 86 y).  
 
 
 Cause of death   
 
In brain-death cadaveric donors, in parallel with the increase in donor age, there has 
also been an increase over the years in the proportion of deaths due to due to 
cerebrovascular accident (CVA) or stroke, in detriment to deaths due to traumatic 
brain damage (TBD). 
 
In 1995, for example, 41.7% of all donors had died due to TBD and 50.0% due to 
stroke, whereas in 2017, these figures were 15.0% and 63.2%, respectively (Figure 
19). 
 
During 1992-2017 period, the mean donor age was 33 years (95% CI, 32.0-34.6 y; 
range, 5-87 y) in deaths due to TBD following traffic accident, 45 years (95% CI, 
43.3-46.9 y; range, 3-85 y) in deaths due to TBD caused by other incidents and 56 
years (95% CI, 55.9-57.0 y; range, 7-86 y) in deaths due to stroke.  
 
The mean age of donors who died due to TBD was 28 years (26 years due to a traffic 
accident and 33 years caused by other incidents) in 1992 and 44 years (34 years due 
to a traffic accident and 53 years caused by other incidents) in 2017. The mean age 
of donors who died due to stroke was 41 years in 1992 and 63 years in 2017.  
 
n
Age (years)
Mean
95% CI
Range
Sex
Men 2563 (60,4%) 43 (87,8%) 28 (73,7%) 58 (61,7%) 64 (61,5%)
Women 1679 (39,6%) 6 (12,2%) 10 (26,3%) 36 (38,3%) 40 (38,5%)
20 - 663 - 87 12 - 65 22 - 73 17 - 57
Brain Death 
Cadaver
Uncontrolled 
Non-Heart-
Beating
Domino Living
4242 49 94 104
Controlled 
Non-Heart-
Beating
38
49,1 - 50,2 39,1 - 47,9 39,5 - 44,8 32,4 - 36
48
43,5 - 51,8
50 43 42 34
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Figure 19. Evolution of Cause of Donor Death: Transplants in Adult Patients. 1992-2017 
 
 
 
 Origin  
 
If we compared transplants from deceased donors in the different periods, there is an 
increase in the proportion of organs generated in the same transplant centre and a 
reduction in organs from the rest of Spain or from abroad. The proportion of organs 
from the rest of Spain increased in the last two periods in comparison with the 
previous period, due to the progressive increase in organs from the autonomous 
community of the Balearic Islands, which are included in this category as they 
correspond to Catalonia as part of the region (Figure 20).  
 
During the 1984-1991 period, 22.7% of transplanted livers from deceased donors 
came from the same transplant centre and 35.5% from other centres in Catalonia, 
these proportions have increased to 32.8% and 43.9% respectively in the 2007-2017 
period.  
 
In 2017, 36.1% (53) of deceased-donor livers came from the same centre, 44.2% 
(65) from other centres in Catalonia and 19.7% (29) from other centres in Spain. 
 
 
 
 
0%
20%
40%
60%
80%
100%
92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17
P
e
rc
e
n
ta
ge
 o
f 
d
o
n
o
rs
Year of transplant
 TBD - traffic accidents  TBD - others  Stroke  Anoxia  Others
Number of cadaveric donors (brain death), 1992-2017 = 4242
Catalan Liver Transplant Registry. 1984-2017 
 28 
Figure 20. Evolution of Donor Origin: Transplants in Adult Patients. 1984-2017 
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Transplant Characteristics 
 
 Emergency 
 
Of the 4888 liver transplants in adults in the 1984-2017 period, 372 (7.6%) were 
urgent. Of these, 62.6% (233) were first transplants, 35.5% (132) were second 
transplants and the remaining 1.9% (7) were third and fourth transplants. 
 
In 2017, 11 (7.3%) urgent transplants were performed, seven first transplants and 
four retransplants.  
 
In the 2012-2017 period, 40.3% of the retransplants were urgent, a higher 
percentage than the last four periods (Figure 21). 
 
Figure 21. Evolution of Urgent Liver Transplants and Number of Transplants: Adult Patients. 
1984-2017 
 
 
 
 Sex compatibility  
 
In the 1992-2017 period, the proportion of transplants with organs from donors of the 
same sex as the recipient was 57.4%; transplants performed on men with a liver from 
a woman represent 25.3% and those on a female recipient from a male donor, 
17.3%.  
 
 
 Blood-group compatibility   
 
The blood group of the receiver and the donor were the same in 95.4% of 
transplants, compatible in 3.8% and incompatible in 0.8%. Over the years, there has 
been a reduction in compatible or incompatible transplants, especially in non-urgent 
transplants (Figure 22). 
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Figure 22. Evolution of ABO Compatibility: Transplants in Adult Patients.1984-2017. 
 
 
 
 Graft type  
 
In 95.2% of the transplants in the registry, a whole organ from a cadaver donor (brain 
death and non-heart-beating) was used, whereas 0.5% were split transplants. If we 
also take into account the organs from domino donors, these percentages are 97.1% 
and 0.5%, respectively. The reduced grafts from live donors represent 2.1%. Both 
split transplants and organs from live donors have oscillated over the last period 
(Table 4).  
Split transplants are usually performed between an adult and a child; two adults have 
been transplanted in only one case. Overall, 27 transplants were performed with split 
grafts, benefitting 25 adults and 27 children. 3 
 
 
 Simultaneous transplants  
 
The first combined liver and kidney transplant was performed in 1988 and 173 of 
these transplants have been carried out since then. In 2017, a total of 12 of these 
transplants were performed –six more than in the previous year. The first combined 
liver and heart transplant was carried out in 2008 and the third one in 2011 (Figure 
23).   
                                               
3
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Table 4. Evolution of Graft Type: Transplants in Adult Patients. 1997-2017 
 
 
 
Figure 23. Evolution of Number of Simultaneous Transplants (Liver-Kidney and Liver-Heart): 
Transplants in Adult Patients. 1988-2017 
 
n % n % n % n %
1997 170 (99,4%) 1 (0,6%) 171
1998 183 (98,9%) 2 (1,1%) 185
1999 183 (98,9%) 2 (1,1%) 185
2000 165 (93,8%) 1 (0,6%) 7 (4,0%) 3 (1,7%) 176
2001 183 (93,8%) 1 (0,5%) 10 (5,1%) 1 (0,5%) 195
2002 175 (92,1%) 13 (6,8%) 2 (1,1%) 190
2003 208 (94,5%) 9 (4,1%) 3 (1,4%) 220
2004 191 (97,9%) 4 (2,1%) 195
2005 206 (95,4%) 1 (0,5%) 7 (3,2%) 2 (0,9%) 216
2006 185 (95,9%) 6 (3,1%) 2 (1,0%) 193
2007 198 (97,1%) 5 (2,5%) 1 (0,5%) 204
2008 198 (96,6%) 6 (2,9%) 1 (0,5%) 205
2009 188 (98,9%) 2 (1,1%) 190
2010 142 (94,0%) 8 (5,3%) 1 (0,7%) 151
2011 175 (98,3%) 3 (1,7%) 178
2012 167 (97,7%) 4 (2,3%) 171
2013 150 (94,9%) 7 (4,4%) 1 (0,6%) 158
2014 142 (95,9%) 5 (3,4%) 1 (0,7%) 148
2015 144 (97,3%) 4 (2,7%) 148
2016 148 (98,0%) 3 (2,0%) 151
2017 148 (98,7%) 1 (0,7%) 1 (0,7%) 150
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 Technique used in anhepatic phase   
  
In 92.2% of the transplants carried out in the 1984-2017 period, the piggy back 
technique was used (with or without portacaval anastomosis). The number of 
transplants using the classic technique has fallen over the years; it was widely used 
in the early years but is currently practically not used at all.  
 
 
 Preservation liquid  
 
The University of Wisconsin preservation solution is the most commonly used (76.8% 
of all transplants in the 1984-2017 period) (Figure 24), although there has been an 
increase in the use of Celsior solution in recent years.  
 
Figure 24. Evolution of Preservation Liquid Type: Transplants in Adult Patients. 1984-2017 
 
 
 
 Ischemia time  
 
The mean time in ischemia has fallen over the years (Figure 25), for the entire 
period, the mean ischemic time was 6.9 hours (median, 6.5 h; range, 0.5-24.0 h). 
From 1992 to 2017, ischemic time fell significantly (p<0.0001) and went from a mean 
of 8.1 hours (95% CI, 7.6-8.6 h; range, 3.2-15.7 h) to 7.0 hours (95% CI, 6.7-7.3 h; 
range, 1.6  -12).  
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Figure 25. Evolution of  Mean Ischemia Time: Transplants in Adult Patients. 1992-2017 
 
 
 
 
 Patient status before transplant  
 
A total of 83.8% of patients who received a transplant in the 1984-2017 period were 
at home, leading a normal life and/or receiving ongoing medical care before 
transplant, 8.5% required conventional hospital care and 7.5% had been admitted to 
an ICU.  
 
Figure 26. Evolution of Patient Status Before Transplant: Transplants in Adult Patients. 1992-
2017 
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Taking into account only patients who received an elective transplant, excluding 
urgent transplants, the proportion of patients who were leading a normal life and/or 
receiving ongoing medical care before transplant has remained stable over the years 
(Figure 26). 
 
 
 Pre-transplant risk factors  
 
Figure 27 shows that hepatic encephalopathy, obesity, diabetes and prior abdominal 
surgery are the most frequent pretransplant risk factors in transplanted patients (first 
transplants) in the 2003-2017 period. 
 
Figure 27. Pre-Transplant Risk Factors: Adult Patients. 2003-2017 
 
 
 
 Immunosuppressors 
 
The study of immunosuppressors was carried out using data collected from 1992 and 
2017 for transplants with information on all drugs. Figure 28 shows the distribution of 
the drugs used in the first month after transplant in 1992 and 2017.  
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Figure 28. Immunosuppressant Drugs Used During the First Month Following Transplant: 
Adults Patients, transplants 1992 and 2017 
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Retransplants 
 
A total of 395 of the 4888 liver transplants carried out from 1984 to 2017 in adult 
patients (8.1%) have been retransplanted (368 first transplants, 25 second 
transplants and two third transplants). Six of these patients received the first 
transplant outside Catalonia or before reaching adult age.  
 
Some 92.0% (4137) of these patients received a single transplant. 7.5% (337) 
received two, 0.5% (23) received three and 0.1% (2) received four.  
 
Of these transplants, 24.9% took place less than a week before having received the 
previous transplant, whereas 41.9% were retransplanted at least a year after the first 
transplant (Figure 29).  
 
Figure 29. Percentage of Retransplants by Time Elapsed Since Previous Transplant: Adult 
Patients. 1984-2017 
 
 
 
Technical complications were the main cause of graft failure (e.g., arterial 
thrombosis), followed by (mostly chronic) rejection (Figure 30). Recurrence of the 
underlying disease was the main cause of failure in the long term (Figure 31).  
 
In terms of the underlying disease of patients who received a retransplant, the three 
most frequent disease groups are cirrhosis (49.4%), hepatocellular carcinoma 
(25.4%) and acute liver failure (10.3%). In the remaining 14.9%, the underlying 
disease was a metabolic disease or other, less frequent, liver disease. 
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Figure 30. Causes of Graft Failure: Adult Patients. 1984-2017 
 
 
 
Figure 31. Percentage of Retransplants by Cause of Graft Failure and Time Elapsed Since 
Previous Transplant: Adult Patients.1984-2017. 
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Survival 
 
Overall survival of adult patients who received a liver transplant in the 1984-2017 
period was 86% at one year, 78% at three years, 72% at five years and 59% at 10 
years. In terms of graft survival, these probabilities fall to 82%, 73%, 66% and 54%, 
respectively (Figure 32). 
 
Overall survival is affected by the characteristics of the transplants carried out in the 
first years, since the number of cases was small and the technique used was new, 
and by factors inherent to the transplants carried out thereafter, such as the inclusion 
of patients with diseases with a poorer outcome and older patients, changes in the 
use of immunosuppressants, advances in surgical techniques and in preservation 
techniques, etc. 
 
Figure 32. Survival of Patient and Graft: Transplants in Adult Patients. 1984-2017 
 
 
  n 3
r 
month 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 15
th
 year 20
th
 year 
Patient 4.486 92% 86% 78% 72% 59% 47% 37% 
Graft 4.876 89% 82% 73% 66% 54% 43% 33% 
 
Patient survival presents statistically significant differences (p=0.012) when the 
number of transplants received is taken into account, although the survival rate 
during the initial years is not very different between those who received a single 
transplant and those who received more than one. At five and 10 years, the 
differences are 0.05 and 0.08, respectively (Figure 33). 
 
 
 Period in which transplant was performed   
 
To adjust the results as much as possible to the context of each stage, five periods 
were defined to analyse survival: 1984-1991, 1992-1996, 1997-2001, 2002-2006, 
2007-2011 and 2012-2017.  
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Figure 33. Survival of Patient by Number of Transplants Received: Adult Patients. 1984-2017 
 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
only 1 tx 4.124 86% 78% 72% 60% 
more than 1 tx 362 83% 73% 67% 52% 
 
 
Figure 34. Survival of Patient by Period in which First Liver Transplant was Received: Adult 
Patients. 1984-2017 
 
 
  1984-1991 1992-1996 1997-2001 2002-2006 2007-2011 2012-2017 
n 315 662 832 942 876 859 
1
st
 year 66% 82% 87% 88% 88% 91% 
3
rd
 year 58% 73% 78% 78% 81% 87% 
5
th
 year 52% 67% 70% 73% 76% 83% 
10
th
 year 41% 53% 60% 60% 65% - 
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Statistically significant differences can be seen by period in both patient survival and 
graft survival (p<0.0001) (Figures 34 and 35). All combinations of two periods are 
statistically significant, except the survival between 1997-2001 and 2002-2006 
period.  
 
Figure 35. Graft Survival by Period: Transplants in Adult Patients. 1984-2017 
 
 
  1984-1991 1992-1996 1997-2001 2002-2006 2007-2011 2012-2017 
n 358 742 911 1.013 926 926 
1
st
 year 57% 76% 82% 84% 86% 88% 
3
rd
 year 49% 65% 73% 74% 78% 82% 
5
th
 year 43% 59% 65% 68% 72% 78% 
10
th
 year 33% 45% 55% 56% 62% - 
 
 
The following survival analyses were carried out using data on transplants carried out 
from 1997, since the current behaviour of liver transplants fits more closely with the 
survival pattern observed in the last three periods. 
 
Patient survival in the 1997-2017 period was 89% at one year, 81% at three years, 
75% at five years and 63% at 10 years. Graft survival for these same times was 85%, 
77%, 70% and 59%, respectively.  
 
 
 Recipient age group  
 
In the long term, the oldest patients have the lowest survival rates. Specifically, in 
patients over the age of 60 years, survival at ten years is 69%, 0.07 less than in 
those aged between 51 and 60 years (Figure 36). 
 
The differences in survival by age of recipient are statistically significant when 
compared with the four groups overall (p<0.0001). Comparisons between two age 
groups show no differences between the ≤30 years and the 31-50 years groups 
(p=0.122), and also between the 31-50 years and 51-60 years group (p=0,078); 
differences between the other age groups are statistically significant.  
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Figure 36. Survival of Patient by Age Group in Which First Liver Transplant was Received: 
Adult Patients. 1997-2017 
 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
≤ 30 y 114 88% 86% 85% 81% 
31-50 y 934 91% 83% 78% 69% 
51-60 y 1.331 90% 83% 76% 65% 
> 60 y 1.130 85% 75% 69% 54% 
 
 
 Indication   
 
In terms of transplant indication, patients with a higher survival rate in the long term 
are those who present a metabolic disease or cholestatic liver disease as an 
indication. The differences between the different indications are statistically 
significant (p<0.0001) (Figure 37).  
 
Patients with hepatocellular carcinoma and cirrhosis present very similar survival 
rates (p=0.057); after the first year, patients with cirrhosis present a slightly higher 
survival rate than patients with hepatocellular carcinoma - at five years, 74% of 
patients with cirrhosis survive compared to 72% of those with a tumour.  
 
The same pattern occurs in graft survival, although there is a more pronounced fall in 
the first two years in transplants where the indication is a cholestatic disease (Figure 
38).  
 
On comparing the survival of patients who present alcoholic cirrhosis, viral cirrhosis 
and hepatocellular carcinoma without another accompanying disease, the differences 
are statistically significant (p=0.006). The differences between viral cirrhosis and 
hepatocellular carcinoma are not statistically significant (p=0.507) (Figure 39).  
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Figure 37. Patient Survival by Indication: Adult Patients. 1997-2017 
 
 
  AHF 
Cholestatic 
Disease 
Cirrhosis HCC 
Metabolic 
Disease 
Others 
n 155 133 1.673 1.302 138 108 
1
st
 year 80% 93% 88% 89% 95% 83% 
3
rd
 year 78% 91% 81% 79% 90% 74% 
5
th
 year 77% 90% 74% 72% 84% 72% 
10
th
 year 73% 81% 63% 58% 75% 66% 
 
 
Figure 38. Graft Survival by Indication: Transplants in Adult Patients. 1997-2017 
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Cholestatic 
Disease 
Cirrhosis HCC 
Metabolic 
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Others 
n 176 151 1.803 1.383 146 117 
1
st
 year 78% 87% 85% 86% 92% 79% 
3
rd
 year 75% 84% 77% 75% 87% 70% 
5
th
 year 70% 81% 70% 68% 80% 68% 
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th
 year 65% 74% 59% 54% 71% 61% 
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Those patients diagnosed with cirrhosis (with or without hepatocellular carcinoma) 
and positive C virus had lower survival rates than patients with only cirrhosis (p < 
0,0001) (Figure 40).  
 
Figure 39. Patient Survival by Indication (Three Groups): Adult Patients. 1997-2017 
 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
Alcoholic Cirr 621 90% 84% 79% 65% 
Virus related Cirr 688 85% 77% 69% 60% 
HCC 1.302 89% 79% 72% 58% 
 
 
Figure 40. Patient Survival by HCV serology: Adult Patients With First Elective Transplant 
diagnosed with cirrhosis, 1997-2017 
 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
HCV positive 1.650 87% 76% 68% 55% 
HCV negative 1.304 92% 86% 81% 69% 
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 Donor age  
 
Patient survival by donor age group for the first transplant shows statistically 
significant differences in the overall comparison (p<0.0001) (Figure 41), and between 
the different groups, except the 56-65 years group and the group of patients over the 
age of 65 years (p=0.173).  
 
Figure 41. Survival of Patient by Donor Age Group: Adult Patients With First Elective 
Transplant. 1997-2017 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
≤ 55 y 1.838 90% 83% 77% 66% 
56-65 y 683 90% 80% 72% 61% 
> 65 y 829 88% 78% 71% 54% 
 
Figure 42. Graft Survival by Donor Age Group: Elective Transplants in Adult Patients. 97-06. 
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In terms of graft survival, there are statistically significant differences (p<0.0001) in 
the overall comparison and between all the groups, except between the 56-65 years 
group and the group of patients over the age of 65 years (p=0.285) (Figure 42).  
 
 
 
 Donor type   
 
No statistically significant differences were found in graft survival by type of donor 
(cadaver, live or domino), although it appears that short-term survival is better in 
domino transplants (Figure 43).  
 
Figure 43. Graft Survival by Donor Type: Elective Transplants in Adult Patients. 1999-2017 
 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
Cadaveric BD 2.913 86% 78% 71% 60% 
Living 103 88% 76% 73% 58% 
Domino 94 90% 80% 75% 60% 
 
 
 
 Cause of donor death  
 
No statistically significant differences (p=0.186) were observed in patient survival 
when cause of first-transplant donor death was taken into account (Figure 44).  
 
There were statistically significant differences in graft survival by cause of donor 
death (p=0.059) (Figure 45).  
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Figure 44. Survival of Patient by Cause of Donor Death (Brain Death): Adult Patients With 
First Elective Transplant. 1997-2017 
 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
TBD 786 89% 82% 76% 65% 
Stroke 1.907 89% 81% 74% 62% 
Anoxia 260 89% 81% 75% 65% 
Others 120 87% 79% 70% 55% 
 
 
Figure 45. Graft Survival by Cause of Donor Death: Elective Transplants in Adult Patients. 
1997-2017 
 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
TBD 831 87% 80% 74% 62% 
Stroke 2.010 86% 77% 70% 58% 
Anoxia 272 85% 76% 70% 59% 
Others 129 83% 75% 67% 53% 
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 Emergency 
 
Patients who received an emergency first transplant have a survival probability 0.11 
lower than the rest of patients, although it is practically the same, at five years, as 
that for patients who underwent an elective transplant (p=0.286) (Figure 46).  
 
Figure 46. Patient Survival by Emergency: Adult Patients. 1997-2017 
 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
Emergency 159 78% 77% 76% 71% 
Elective 3.350 89% 81% 74% 62% 
 
 
Differences for graft survival were statistically significant (p<0.0001) (Figure 47).    
 
Figure 47. Graft Survival by Emergency: Transplants in Adult Patients. 1997-2017 
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 year 3
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 year 5
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 year 10
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Emergency 252 73% 67% 63% 56% 
Elective 3.524 86% 77% 71% 59% 
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 ABO compatibility  
 
Patients who received a liver from an identical ABO donor have a higher survival rate 
than those for whom compatibility was not perfect; the differences aren’t significant 
(p=0.317) (Figure 48).  
 
Figure 48. Survival of Patient by ABO Compatibility: Adult Patients With First Elective 
Transplant. 1997-2017 
 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
Isogroup 3.302 89% 81% 75% 63% 
Compatible 46 91% 73% 60% 57% 
 
Figure 49. Graft Survival by ABO Compatibility: Elective Transplants in Adult Patients. 1997-
2017 
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 year 3
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 year 5
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 year 10
th
 year 
Isogroup 3.471 86% 77% 71% 59% 
Compatible 51 88% 72% 61% 58% 
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Neither were differences statistically significant for graft survival (Figure 49).  
It must be remembered that there is a low number of non-identical compatible cases 
and that incompatible cases were not included.  
 
 
 Ischemic time  
 
Overall, the differences observed in graft survival by hours elapsed in ischemia are 
statistically significant (p=0.009). Those grafts with over nine hours ischemic time 
have poorer survival rates (Figure 50).   
 
Figure 50. Graft Survival by Ischemic Time: Transplants in Adult Patients. 1997-2017 
 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
< 6 h 1.488 88% 79% 72% 59% 
 6-9 h 1.449 86% 78% 71% 60% 
> 9 h 561 83% 73% 67% 55% 
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Mortality 
 
Of the 4499 adult patients in the registry, 52.4% (2356) were still alive as at 31 
December 2017 and 46.4% (2088) had died. This information was not available due 
to lost follow-up in 1.2% (55).   
 
In 9.8% (205) of deceased patients, death occurred during the first month after the 
first transplant (Figure 51).  
 
Figure 51. Patients Deceased by Time Elapsed Between Death and First Transplant: Adult 
Patients. 1984-2017 
 
 
 
The main causes of death in adult patients were recurrence of the underlying disease 
(28.2%) and infections (17.3%) (Figure 52). Recurrence of the underlying disease 
was the main cause of death in the long term (Figure 53).  
 
Mortality was analysed in percentages in relation to the period (year of death). The 
1984-1991 period has a considerably higher mortality rate (20.3%); mortality is less 
than half of this figure for the following periods (1992-1996, 7.6%; 1997-2001, 5.6%; 
2002-2006, 5.2%; 2007-2011, 4.5%; 2012-2017: 4.1%). Figure 54 shows the 
distribution of the main causes of death by period; a reduction can be seen in 
mortality due to infection, extrahepatic complications and rejection.  
 
Recurrence of the underlying disease, infections, extrahepatic complications and de 
novo tumours are the main causes of death in adult patients who received a single 
liver transplant. Recurrences, infections and extrahepatic complications are also the 
main cause of death in patients who received a second transplant; in these cases, 
however, they are followed by rejection and technical complications (Table 5).  
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Figure 52. Causes of Death: Adult Patients. 1984-2017 
 
 
 
Figure 53. Mortality by Cause of Death and Time Elapsed Since First Transplant: Adult 
Patients who Received a Single Liver Transplant. 1984-2017 
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Figure 54. Distribution of the Main Causes of Death by Period (Year of Death) in Percentages 
(per 100 People/Year): Adult Patients. 1984-2017 
 
 
 
Table 5. Evolution of Cause of Death by Number of Transplants Received: Adult Patients. 
1984-2017 
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Waiting List 
 
The number of patients on the waiting list at the end of 2017 was lower than in 
previous years, going from 149 to 117 (Figure 55).  
 
Figure 55. Evolution of Number of Transplants and Number of Patients on Waiting List at End 
of Year: Adult Patients. 2000-2017 
 
 
 
Figure 56. Evolution of Mortality Percentage on Waiting List: Adult Patients. 2000-2017 
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In 2017, the mean number of days waiting for a liver transplant was 214 days, 
excluding urgent transplants, the waiting time was 231 days.  
 
In 2017, 167 adults were included in the list and 46 were excluded (transplant not 
included), the percentage of transplant on the list was 46.4%. Of the total number of 
exclusions, 15 were due to death, which represented a mortality rate on the waiting 
list of 4.7%, and 10 were due to definitive exclusions (3.1%). Compared to 2016, 
there was no change in exclusions due to death and definitive exclusions in 2017 
(Figure 56).  
 
In the 2000-2017 period, the probability of receiving a liver transplant was 55% after 
six months on the waiting list and 73% after one year (Figure 57).  
 
Figure 57. Probability of Receiving a Transplant: Adult Patients. 2000-2017 
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Living donor liver transplant 
 
The first living donor liver transplant in adults was performed in 2000 and 104 of 
these transplants have been carried out since then. In 2017, one transplant was 
performed.  
 
 
Recipient Characteristics 
 
A total of 69.2% (72) of the patients who received a living donor transplant were men 
and 30.8% (32) women.  
 
The mean age of recipients was 55 years, the median was 57 years and the range 
was 23-69 years, with regards to distribution by age groups; 2.9% (3) of patients 
were under 30 years, 23.1% (24) 31-50 years, 39.4% (41) 51-60 years and 34.6% 
(36) over 60 years.  
 
Cirrhosis (without hepatocellular carcinoma) is the most frequent indication, 
representing 52.9% of all patients, the second one (43.3%) is hepatocellular 
carcinoma (Figure 58). 62.5% of the patients who received a living donor transplant 
are HCV positive.  
 
Figure 58. Principal Diagnosis of Patients Who Received a Living Donor Liver Transplant: 
Adult Patients.2000-2017. 
 
 
 
 
Survival and Mortality  
 
Overall survival of adult patients who received a living donor liver transplant in the 
2000-2017 period was 93% at one year and 77% at five years. In terms of graft 
survival, these probabilities are 88% and 73% respectively (Figure 59). 
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Figure 59. Survival of Patient and Graft: Living Donor Transplants in Adult Patients. 2000-
2017 
 
 
  n 3
r 
month 1
st
 year 3
rd
 year 5
th
 year 7
th
 year 10
th
 year 
Patient 104 96% 93% 80% 77% 68% 62% 
Graft 104 92% 88% 76% 73% 64% 58% 
 
 
Nine (8.7%) grafts failed and needed a retransplant from a brain-death cadaveric 
donor, three of them before the first week (national emergency) and one between the 
first week and the first month (local emergency).  
 
Of the 104 adult patients, 56.7% (59) were still alive as of 31st December 2017 and 
43.3% (45) had died.  
 
Of the 45 deceased patients, 7 (15.6%) died between the first month and the first 
year of transplant, 13 (28.9%) died between the first and third year, 3 (6.7%) died 
between the third and fifth year and 22 (48.9%) died after the fifth year.  
The most frequent causes of death were recurrence of the underlying disease 
(44.4%), infections (17.8%) and technical complications (8.9%).  
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Domino donor liver transplant 
 
The first domino donor liver transplant in adults was performed in 1999 and 94 of 
these transplants have been carried out since then; 89 first transplants and 5 
retransplants. In 2017, two transplants were performed.  
 
 
Recipient Characteristics 
 
Of the 89 patients who received a first domino donor liver transplant, 61 (68.5%) 
were men and 28 (31.5%) women.  
 
For these patients, the mean and median age was 63 years and the range 52-69 
years, 76.4% (68) of patients were over 60 years.  
 
Cirrhosis (without hepatocellular carcinoma) and hepatocellular carcinoma were the 
most common indications and represent 42,7% and 51,7%, respectively, of the 
patients who received a first domino donor liver transplant (Figure 60). 60.7% of the 
patients are HCV positive.  
 
Figure 60. Principal Diagnosis of Patients Who Received a First Domino Donor Liver 
Transplant: Adult Patients.1999-2017. 
 
 
 
 
Survival and Mortality  
 
Overall survival of adult patients who received a first domino donor liver transplant in 
the 1999-2017 period was 92% at one year and 76% at five years. In terms of graft 
survival, these probabilities are 90% and 74% respectively (Figure 61). 
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Figure 61. Survival of Patient and Graft: Domino Donor Transplants in Adult Patients. 1999-
2017 
 
  n 3
r 
month 1
st
 year 3
rd
 year 5
th
 year 7
th
 year 10
th
 year 
Patient 89 97% 92% 81% 76% 71% 61% 
Graft 89 94% 90% 78% 74% 70% 60% 
 
 
Two (2.2%) grafts failed and needed a retransplant from a brain-death cadaveric 
donor before the first week (emergency).  
 
Of the 94 adult patients, 51.1% (48) were still alive at 31st December 2017 and 48.9% 
(46) had died.  
 
Of the 46 deceased patients, 7 (15.2%) died between the first month and the first 
year of transplant, 10 (21.7%) died between the first and third year, 4 (8,7%) died 
between third and fifth year and 25 (54.3%) died after the fifth year.  
The most frequent causes of death were recurrence of the underlying disease 
(34.8%), infections (15.2%), tumour de novo (8.7%) and extrahepatic complications 
(8.7%).  
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Liver Transplants in Children 
 
Of the 5215 transplants carried out in Catalonia in the 1984-2017 period, 327 were 
performed in children (287 first transplants and 40 retransplants). In 2017, a total of 
10 transplants were performed, all first transplants.  
 
The paediatric transplant workload varies from one year to another and there is no 
clear trend upwards or downwards in the workload (Figure 62). 
 
Figure 62. Evolution of Number of Liver Transplants: Paediatric Patients. 1985-2017 
 
 
 
Recipient Characteristics 
 
 Sex and age  
 
A total of 51.2% (147) of patients who received a first transplant were boys and 
48.8% (140) were girls. 
 
The mean age for the 1984-2017 period was four years (95% CI.3.9-5.0 y; range. 17 
days-17 years), although 49.8% (143) of patients were 2 years of age or younger.  
 
In 2017, 7 (70.0%) patients were boys and 3 (30.0%) were girls. The mean age was 
4 years with the range from age 8 months to 10 years. Five patients (50.0%) were 2 
years of age or younger.  
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 Indications  
 
Indications are stratified into six groups: acute liver failure, cholestatic liver disease, 
congenital biliary disease, cirrhosis, tumours, metabolic disease and others (Budd-
Chiari and polycystic disease), in accordance with the code recorded in the principal 
diagnosis.  
Congenital biliary disease is the most frequent indication, with 51.2% (147) of 
transplanted patients, mostly corresponding to biliary atresia (133 of 147 cases). The 
second most frequent indication (57 patients; 19.9%) was metabolic diseases (Figure 
63).  
 
Figure 63.Principal Diagnosis of First Liver Transplant: Paediatric Patients. 1985-2017 
 
 
 
By age, 72.7% (104) of children aged 2 years or younger had a congenital biliary 
disease, whereas only 29.9% (43) of children aged between 3 and 17 years had this 
indication (Figure 64). This means that 70.7% of patients with a congenital biliary 
disease are aged 2 years or younger.    
 
Over the years, congenital biliary disease has remained the most frequent indication, 
representing 55.9% of indications for the 1984-1991 period and 38.6% for the 2012-
2017 period. The percentage of patients with a metabolic disease had decreased in 
the first periods and risen in the last one, representing, in the 2012-2017 period, 
28,6% of all the patients. Given the small number of cases, it was not possible to 
evaluate the evolution of the other liver diseases (Figure 65).  
 
In 2017, 60,0% (6) of the patients have a congenital biliary disease, 20,0% (2) a 
metabolic disease, 10,0% (1) a cholestatic liver disease and 10,0% (1) a tumour.  
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Figure 64. Principal Diagnosis of First Liver Transplant by Age Group: Paediatric Patients. 
1985-2017 
 
 
 
Figure 65. Principal Diagnosis of First Liver Transplant by Period: Paediatric Patients. 1985-
2017 
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Donor Characteristics 
 
 Age and sex 
 
The mean donor age in the 1992-2017 period was 17 years (95% CI.15.3-19.2 y; 
range. 1-63 y). Over the years, the mean age has oscillated, with a slight tendency to 
increase due to the increased maximum donor age (split graft transplant, emergency 
0 transplants and living donors).  
 
In the same period, 57.3% of donors were men and 42.7% were women.  
 
 
 Donor type 
 
The first living donor transplant was performed in 2003, a total of 43 of these 
transplants has been performed. Organs from living donors represented 13.1% of all 
organs transplanted in the 1984-2017 period: the remaining 86.9% (284) came from 
cadaver donors due to brain death (16.7% and 83.3% respectively in 1992-2017 
period). 
 
 
 Cause of death 
 
In the 1992-2017 period, 47.9% (102) of donors died due to craneoencephalic 
trauma, 24.9% (53) due to cerebrovascular accident, 15.9% (34) due to anoxia and 
11.3% (25) due to other causes.  
 
 
 Origin   
 
A total of 14.0% (30) of deceased donors in paediatric transplants carried out in the 
1992-2017 period came from the same centre and 23.8% (51) came from another 
centre in Catalonia, whereas 48.6% (104) came from the rest of Spain and 13.6% 
(29) from abroad.  
 
 
Transplant Characteristics 
 
 Emergency 
 
Of the 327 transplants carried out in the 1984-2017 period, 16.8% (55) were urgent, 
of these, 63.6% (35) were first transplants and 36.4% (20) were retransplants.  
 
 
 Graft type   
 
In 62.1% (203) of paediatric transplants carried out in the 1984-2017 period, a whole 
organ from a cadaver donor was used, a reduced organ was used in 16.2% (53) and 
a split graft in 8.3% (27). Reduced grafts from living donors represent 13.1% (43).  
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 Simultaneous transplants: liver-kidney 
 
The first simultaneous liver and kidney transplant was carried out in 2000 and 12 of 
these transplants have been performed since then.   
 
 
 Patient status before transplant 
 
Prior to transplant, 66.1% of patients who underwent a transplant in the 1984-2017 
period were living at home leading a normal life and/or receiving ongoing medical 
care, 11.6% required conventional hospital care and 19.6% were admitted to an ICU.  
 
 
Retransplants 
 
Of the 327 paediatric transplants performed in the 1984-2017 period, 40 (12.2%) 
were retransplants (287 first transplants, 34 second transplants and six third 
transplants). One patient required a retransplant after becoming an adult.  
 
Some 88.2% (253) of these patients received a single transplant, 9.8% (28) received 
two and the remaining 2.1% (6) received three.  
 
Of the 40 failed grafts, 10 (25.0%) failed before the first week, 10 (25.0%) after the 
first week and before three months, five (12.5%) after the fourth month and before 
one year and the remaining 15 (37.5%) after one year.  
 
The principal cause of failure was rejection (14; 35.0%), followed by technical 
complications (11; 27.5%) and primary non-function (8; 20.0%). In most cases of 
graft failure that occurred during the first month, the cause was primary non-function, 
whereas chronic rejection was the principal cause in cases where failure occurred at 
a later stage.  
 
 
Survival 
 
Overall survival of children who received a liver transplant in 1984-2017 period was 
85% at one year and 74% at 10 years (Figure 66). Graft survival is slightly lower than 
patient survival - 0.08 less in the first year and 0.10 lower at 10 years.  
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Figure 66. Survival of Patient and Graft: Paediatric Patients. 1985-2017 
 
  n 3
r 
month 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 15
th
 year 20
th
 year 
Patient 287 88% 85% 81% 77% 74% 74% 74% 
Graft 327 82% 77% 73% 69% 64% 63% 63% 
 
 
 Period in which transplant was performed   
 
When survival is analysed by the period in which the transplant was performed, the 
probability of survival increases considerably in the first and third year in the later 
periods (Figures 67 and 68).  
 
Figure 67. Survival of Patient by Period: Paediatric Patients. 1985-2017 
 
  1984-1991 1992-1996 1997-2001 2002-2006 2007-2011 2012-2017 
n 59 41 28 46 43 70 
1
st
 year 68% 78% 82% 91% 91% 97% 
3
rd
 year 61% 68% 82% 85% 91% 97% 
5
th
 year 53% 63% 82% 85% 91% 93% 
10
th
 year 47% 60% 82% 83% 88% - 
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Figure 68. Survival of Graft by Period: Paediatric Patients. 1985-2017 
 
 
  1984-1991 1992-1996 1997-2001 2002-2006 2007-2011 2012-2017 
n 70 49 36 52 48 72 
1
st
 year 59% 65% 72% 83% 88% 96% 
3
rd
 year 50% 59% 72% 75% 88% 96% 
5
th
 year 44% 50% 72% 75% 88% 92% 
10
th
 year 39% 46% 66% 73% 83% - 
 
 
The differences in both patient and graft survival for the different periods studied are 
statistically significant, but this difference was not found between the first and second 
period or between the four last periods.  
 
To provide a more up-to-date vision of the results, we analysed survival rates using 
data on transplants carried out from 1997. In the 1997-2017 period, patient survival 
was 92% in the first year and 89% in the third and fifth year. 
 
 
 Age  
 
When the child’s age is taken into account, the children aged 2 years or younger 
have a lower survival rate than children aged between 3 and 14 years (p = 0.063) 
(Figure 69).   
 
 
 Indication   
 
Given the small number of transplants carried out on children, it was not possible to 
analyse survival in the different groups of indications; two unique groups were 
therefore created for children with or without congenital biliary disease.  
 
Children who received a liver transplant in the 1997-2017 period due to a congenital 
biliary disease had a higher survival rate than patients with other indications, 
although the differences between the two groups were not significant (Figure 70).  
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Figure 69. Survival of Patient by Age: Paediatric Patients. 1997-2017 
 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
≤ 2 y 102 87% 86% 86% 84% 
3-17 y 85 98% 95% 93% 91% 
 
 
Figure 70. Survival of Patient by Indication (congenital biliary disease or others): Paediatric 
Patients. 1997-2017 
 
 
  n 1
st
 year 3
rd
 year 5
th
 year 10
th
 year 
Cong. Biliary disease 89 95% 94% 94% 92% 
Other indications 98 89% 86% 85% 83% 
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Mortality 
 
Some 70.4% (202) of the 277 patients transplanted were living as at 31 December 
2017 and 24.0% (69) had died. This information was not available due to lost follow-
up in 5.6% (16) 
 
Of the 69 deceased patients, 23 (33.3%) died before one month after the first 
transplant and 26 (37.7%) died after the first year.  
 
The most common causes of death were infections and extrahepatic complications 
(Figure 71).  
 
Figure 71. Cause of Death: Paediatric Patients. 1985-2017 
 
 
 
Waiting List 
 
A total of 233 patients were included in the waiting list in the 2000-2017 period; 
82.4% received a transplant and 17 patients died while awaiting a transplant.  
In 2017, there were 11 inclusions on the waiting list; nine patients remained on the 
list as at 31 December.  
 
Source: Donor and Transplant Registry.  
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Living donor liver transplant 
 
In 2003 the first living donor liver transplant in children was performed and 43 of 
these transplants have been carried out since them. In 2017, four transplants were 
performed.  
 
Of these 43 patients, 60.5% (26) were boys and 39.5% (17) girls, the mean age was 
2 and the median was one year and the range was between 4 months and 8 years. 
69.8% (30) of patients were 2 years of age or younger 
 
23 (53.5%) patients have biliary atresia (congenital biliary disease), 8 (18.6%) 
metabolic disease, 6 (14.0%) tumour (hepatoblastoma or hepatocellular carcinoma) 
and 6 (14.0%) other type of liver disease.  
 
Overall survival of children who received a living donor liver transplant in the 2003-
2017 period was 98% at one year and 94% at five year (Figure 72). Two (4.7%) 
grafts failed and needed a retransplant.  
 
Figure 72. Survival of Patient and Graft: Living Donor Transplants in Paediatric Patients. 
2003-2017 
 
 
  n 3
r 
month 1
st
 year 3
rd
 year 5
th
 year 7
th
 year 
Patient 43 98% 98% 98% 94% 0% 
Graft 43 95% 93% 93% 89% 0% 
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